Gurmen, AlperGuclu, OrkutHuseyin, SerhatCan, NurayOzgun, ErayBuyukadali, MurselReyhancan, Adem2024-06-122024-06-1220231995-18921680-0745https://doi.org/10.5830/CVJA-2023-061https://hdl.handle.net/20.500.14551/21979Introduction: The aim of this study was to investigate the effects of ellagic, vanillic and rosmarinic acid on reperfusion-related kidney damage, developed in an experimental lower-extremity ischaemia/reperfusion (I/R) model.Methods: Forty-eight female Sprague-Dawley rats were divid-ed into six groups. A median laparotomy and dissection were performed. In the I/R group, 60 minutes of ischaemia followed by 120 minutes of reperfusion was achieved. In addi-tion one group was given 100 mg/kg ellagic acid, one group was given 12 mg/kg vanillic acid, one group was given 50 mg/ kg rosmarinic acid and one group was given all three drugs 15 minutes before clamp removal. Bilateral kidney and blood samples were taken in all groups.Results: Tubular epithelial degeneration, necrosis of the tubule epithelium and vessel wall thickening were significantly higher in the I/R group. Some parameters in the groups that were given drugs were found to be lower than in the I/R group and close to that of the control group. Total oxidant status (TOS) and oxidative stress index (OSI) were significantly higher and total antioxidant status (TAS) was significantly lower in the I/R group. Although not statistically significant in the groups given drugs, TAS was higher, and TOS and OSI were lower than in the I/R group.Conclusion: The antioxidant effect of ellagic, vanillic and rosmarinic acid administration may have beneficial effects on renal damage after reperfusion in acute lower-extremity ischaemia. This study is expected to provide information for future clinical trials.en10.5830/CVJA-2023-061info:eu-repo/semantics/closedAccessIschaemia/ReperfusionRenal InjuryEllagic AcidVanillic AcidRosmarinic AcidOxidative StressIschemiaHistopathologyLiverInvestigation of the effects of ellagic, vanillic and rosmarinic acid on reperfusion-induced renal injuryArticleN/AWOS:00111339830000138032731